CELSUS THERAPEUTICS PLC - 15119A202
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | History | New | 673,887 | 4,374 | 0.06% | — | 1 | +673,887 | New | Q1 2014 | May 15, 2014 |
| SABBY MANAGEMENT, LLC | History | New | 669,080 | 4,342 | 0.24% | — | 2 | +669,080 | New | Q1 2014 | May 14, 2014 |
| Broadfin Capital, LLC | History | New | 470,877 | 3,056 | 0.3% | — | 3 | +470,877 | New | Q1 2014 | May 15, 2014 |
| Cormorant Asset Management, LLC | History | New | 103,000 | 668 | 0.15% | — | 4 | +103,000 | New | Q1 2014 | May 15, 2014 |
| DAFNA Capital Management LLC | History | New | 43,900 | 285 | 0.24% | — | 5 | +43,900 | New | Q1 2014 | May 15, 2014 |
| Knoll Capital Management, LP | History | New | 23,255 | 151 | 0.08% | — | 6 | +23,255 | New | Q1 2014 | May 15, 2014 |
| CITIGROUP INC | History | New | 2,460 | 16 | 0.0% | — | 7 | +2,460 | New | Q1 2014 | May 15, 2014 |
| Tower Research Capital LLC | History | New | 465 | 3 | 0.0% | — | 9 | +465 | New | Q1 2014 | May 02, 2014 |
| UBS AG | History | New | 395 | 3 | 0.0% | — | 8 | +395 | New | Q1 2014 | May 16, 2014 |
| MORGAN STANLEY | History | New | 7 | 0 | — | — | — | +7 | New | Q1 2014 | May 13, 2014 |